(Q40366933)

19 September 2017

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial (English)

1 reference

19 September 2017

0 references

Dominic Snijders

1

1 reference

19 September 2017

Johannes M A Daniels

2

1 reference

19 September 2017

Casper S de Graaff

3

1 reference

19 September 2017

Tjip S van der Werf

4

1 reference

19 September 2017

Wim G Boersma

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

4 February 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

19 September 2017

1 reference

19 September 2017

181

1 reference

19 September 2017

9

1 reference

19 September 2017

975-982

1 reference

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

19 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Novel targets in the management of pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Patterns of cytokine expression in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Effects of systemic steroids in patients with severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Effects of glucocorticoids in ventilated piglets with severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Severe community-acquired pneumonia. Assessment of severity criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Adrenal function in patients with community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

The influence of COPD on mortality and severity scoring in community-acquired pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

Therapy for pneumococcal bacteremia: monotherapy or combination therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0808OC

10.1164/RCCM.200905-0808OC

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference